When AI Starts Designing Biology, Who Owns the Evidence Chain?
A new $95 million AI BioDesign initiative will put AI models and physical biology experiments into a continuous feedback loop. When an AI-designed molecule reaches the lab, can we reconstruct exactly how it came to exist?